Reimbursement
Keeping an Eye on 8 New Payment Trends
Creating financial sustainability and managing time-consuming and frustrating payment policies are continuing ...
AUGUST 25, 2025
CMS Proposed Outpatient Payment Rule Threatens Essential Funding, ASHP Argues
CMS has released one of its largest annual proposed payment rules, the Hospital Outpatient Prospective Payment ...
AUGUST 14, 2025
Best of ASHP 2025: Increasing Importance of Data Integrity in the Revenue Cycle
Bonnie Kirschenbaum details how valuable accurate data can be within the reimbursement system for both payers, ...
JULY 2, 2025
Let’s Not Forget About Revenue-Generating Processes!
Healthcare is undergoing several drastic changes, including workforce reductions, tariffs that may lead to major ...
MAY 23, 2025
Here’s How to Properly Bill for Wasted Drugs
The fundamental principle in billing for wasted drugs is that the medication in specific types of manufacturer ...
FEBRUARY 6, 2025
Heads Up: 8 Payment Changes and Challenges in 2025!
We’ve entered a new year and a new era with major proposed changes to healthcare. How sturdy are your three ...
JANUARY 16, 2025
NASP Urges Action on ‘Abysmal’ Medicare Part D Reimbursement
Medicare Part D contract rates for specialty pharmacies for 2024 and 2025 are “abysmal,” said Julie ...
NOVEMBER 20, 2024
The NOPAIN Act: Clinical and Financial Opportunities in Hospital Outpatient and Ambulatory Settings
This monograph features the clinical perspectives from those working in the trenches of postsurgical pain ...
OCTOBER 14, 2024
NASP Urges Action on 'Abysmal' Medicare Reimbursement
Medicare Part D contract rates for specialty pharmacies for 2024 and again in 2025 are “abysmal,” Julie ...
OCTOBER 12, 2024
Offsetting High Drug Costs Is a Moving Target
One of Medicare’s primary reimbursement policies adds costs to a health system that is already spending at ...
SEPTEMBER 5, 2024
FAQs on Key Payment Issues
Several readers asked for assistance in understanding payment issues at their facilities.
MAY 9, 2024
Finances May Hinge on Biosimilars, PAs
This month’s column primarily covers two major issues confronting pharmacy: prior authorization and the ...
APRIL 18, 2024
